Phenazopyridine for Confirmation of Ureteral Patency

Use of Phenazopyridine for Confirmation of Ureteral Patency During Intraoperative Cystoscopy

In this prospective, randomized trial subjects will be randomized to receive phenazopyridine or no medication prior to pelvic reconstructive procedures that use cystoscopy to confirm ureteral patency intraoperatively.

Inclusion Criteria:

• Females only
• Planned surgical procedure where cystoscopy will be used to document ureteral urine flow
• Age > or = 18 years, no upper age limit
• Able and willing to consent

Exclusion Criteria:

• Planned surgical procedure where cystoscopy will not be used
• Planned surgical procedure where cystoscopy is used for a purpose other than documenting ureteral urine flow
• age <18 years
• pregnancy
• unable/unwilling to participate
• history of allergy or adverse reaction to phenazopyridine
• hepatic dysfunction
• known phenazopyridine hypersensitivity
• history of urologic surgery
• presence of ureteral stents prior to the planned surgical procedure
• concomitant suprapubic catheter placement